Evidence map›Paper›PMID 26721319›Full record

ArticleNeurobiology of disease2016

Optogenetic activation of superior colliculus neurons suppresses seizures originating in diverse brain networks.

Colin Soper, Evan Wicker, Catherine V Kulick, Prosper N'Gouemo, Patrick A Forcelli

Open access · greenAbstract read
In one paragraph

Article in Neurobiology of disease, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 82 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Optogenetic stimulation of the dorsal striatum bidirectionally controls seizures.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Towards translational optogenetics.Nature biomedical engineering · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Distinct Fastigial Output Channels and Their Impact on Temporal Lobe Seizures.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Colin SoperDepartment of Pharmacology & Physiology, Georgetown University, Washington, DC 20007.
Evan WickerDepartment of Pharmacology & Physiology, Georgetown University, Washington, DC 20007.
Catherine V KulickDepartment of Pharmacology & Physiology, Georgetown University, Washington, DC 20007.
Prosper N'GouemoInterdisciplinary Program in Neuroscience, Georgetown University, Washington, DC 20007; Department of Pediatrics, Georgetown University, Washington, DC 20007.
Patrick A ForcelliDepartment of Pharmacology & Physiology, Georgetown University, Washington, DC 20007; Interdisciplinary Program in Neuroscience, Georgetown University, Washington, DC 20007. Electronic address: Paf22@georgetown.edu.
Georgetown University · US

Funding

Maternal Morbidity and Mortality: Risk Factors, Early Detection and Personalized InterventionUL1TR001409 · NCATS · GEORGETOWN UNIVERSITY · PI GONDRE-LEWIS, MARJORIE C, MELLMAN, THOMAS A · 2015 to 2024
$37.8M
Georgetown-Howard Universities Center for Clinical and Translational Science (GHUUL1TR000101 · NCATS · GEORGETOWN UNIVERSITY · PI MELLMAN, THOMAS A, VERBALIS, JOSEPH G · 2012 to 2015
$19.3M
Institutional Career Development CoreKL2TR001432 · NCATS · GEORGETOWN UNIVERSITY · PI UMANS, JASON G · 2015 to 2024
$7.5M
Mechanisms of Alcohol Withdrawal Seizures: Role of L-type Ca2+ ChannelsR01AA020073 · NIAAA · GEORGETOWN UNIVERSITY · PI N'GOUEMO, PROSPER · 2011 to 2015
$1.7M
Postdoctoral Training in Developmental Disabilities ResearchT32HD046388 · NICHD · CHILDREN'S RESEARCH INSTITUTE · PI VITTORIO GALLO, VITTORIO GALLO VITTORIO GALLO · 2006 to 2016
$1.5M
NCATS NIH HHS KL2 TR001432NCATS NIH HHS KL2TR001432NCATS NIH HHS UL1 TR000101NCATS NIH HHS UL1TR000101NCATS NIH HHS UL1 TR001409NCATS NIH HHS UL1TR001409NIAAA NIH HHS AA020073NIAAA NIH HHS R01 AA020073NICHD NIH HHS HD046388NICHD NIH HHS T32 HD046388
6 · The paper itself

Abstract

Because sites of seizure origin may be unknown or multifocal, identifying targets from which activation can suppress seizures originating in diverse networks is essential. We evaluated the ability of optogenetic activation of the deep/intermediate layers of the superior colliculus (DLSC) to fill this role. Optogenetic activation of DLSC suppressed behavioral and electrographic seizures in the pentylenetetrazole (forebrain+brainstem seizures) and Area Tempestas (forebrain/complex partial seizures) models; this effect was specific to activation of DLSC, and not neighboring structures. DLSC activation likewise attenuated seizures evoked by gamma butyrolactone (thalamocortical/absence seizures), or acoustic stimulation of genetically epilepsy prone rates (brainstem seizures). Anticonvulsant effects were seen with stimulation frequencies as low as 5 Hz. Unlike previous applications of optogenetics for the control of seizures, activation of DLSC exerted broad-spectrum anticonvulsant actions, attenuating seizures originating in diverse and distal brain networks. These data indicate that DLSC is a promising target for optogenetic control of epilepsy.

Indexed as

4-ButyrolactoneAcoustic StimulationAnimalsBrain StemDisease Models, AnimalElectrocorticographyEpilepsyMaleNeuronsOptogeneticsPentylenetetrazoleProsencephalonRats, Sprague-DawleySuperior ColliculiThalamus4-ButyrolactonePentylenetetrazoleAbsence epilepsyChannelrhodopsin-2Deep brain stimulationGeneralized epilepsyPartial seizureRatTemporal lobe epilepsy

Identifiers

PMID26721319
PMCPMC4724547
OpenAlexW2202510332

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.